Oxford Global Conferences are proud to present our 3rd Annual Vaccines Congress, taking place on the 25th & 26th March 2013 at the Novotel London West.

 

Experts calculate the global vaccine industry will be worth $52bn in 2016, more than double the total for 2009. The increased acceptance of adult vaccines, in conjunction with the growing focus on neglected diseases has highlighted the significant role vaccines play in the future of the pharmaceutical industry. This event will offer vital insights into the core strategies and technologies shaping the future of the vaccines industry and is a must for anyone working in the field of vaccines.

 

The conference programme consists of world-class keynote addresses, industry and academic led presentations and ample networking opportunities creating an interactive platform for high-level scientific and business discussions.

 

On Day One, our delegates will hear from those working at the forefront of vaccine discovery and development in areas including allergy vaccines, infectious diseases and tropical diseases. Our panel of experts will also discuss novel DNA and RNA based approaches to vaccine development, as well as giving invaluable insights into the latest technological advances.

 

On Day Two, presentations will explore the current challenges and solutions in clinical trial design, critical opportunities in the emerging markets as well as key regulatory updates. Our distinguished speakers will discuss the most important updates in adjuvant technologies, novel administration methods and vector vaccines.